Form 4 for LH Labcorp
Accepted 2022-03-29 00:00:00 ET · period of report 2022-03-27 · accession 0001127602-22-010505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-29 | 2022-03-28 | LH | Caveney Brian J | EVP, Pres of Diagnostics | F - Tax | $276.42 | -1,883 | 14.1K | -12% | -$520.5K | |
| 2022-03-29 | 2022-03-27 | LH | Caveney Brian J | EVP, Pres of Diagnostics | A - Grant | $0.00 | +4,241 | 16.0K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-28 | F | D | 1,883 | $276.42 | 14,129.91 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-27 | A | A | 4,241 | $0.00 | 16,012.91 | D | — | — |